
Profiled company: Plandaí Biotechnology, Inc. (PLPL)
Plandaí Biotechnology, Inc. (PLPL) and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions.
According to an Apr. 1 press release, PLPL controls every aspect of the process, from growing the raw materials
...read more
Stocks covered:
|
Compensation:
|
Avg $ Volume for Period:
|
PLPL
|
$7,000
|
UNKNOWN
|
Max Profit: 6.10 %
|
Gain at close: Pending
|